vaccines

Following Merck approval, Gavi authorizes $178M to build Ebola vaccine stockpile
Following Merck approval, Gavi authorizes $178M to build Ebola vaccine stockpile
Fierce Pharma
Merck
vaccines
ebola virus
Ervebo
GAVI
Flag link:
Merck Isn't Too Reliant on Keytruda Yet, and That's Good News for Investors
Merck Isn't Too Reliant on Keytruda Yet, and That's Good News for Investors
Motley Fool
Merck
Keytruda
vaccines
China
Flag link:
6 Things About Biopharma to Be Thankful For
6 Things About Biopharma to Be Thankful For
BioSpace
innovation
vaccines
investors
Flag link:
Another cancer vaccine play out of Geneva shoots for 'hard endpoint' in PhII head and neck cancer test
Another cancer vaccine play out of Geneva shoots for 'hard endpoint' in PhII head and neck cancer test
Endpoints
MaxiVAX
cancer
vaccines
cancer vaccines
solid tumors
head and neck cancer
Flag link:
Takeda's dengue vaccine efficacy slips between 12- and 18-month analyses
Takeda's dengue vaccine efficacy slips between 12- and 18-month analyses
Fierce Pharma
Takeda
vaccines
dengue
TAK-003
Flag link:
GlaxoSmithKline's Shingrix supply will vault upward, CEO says—in 2024, that is
GlaxoSmithKline's Shingrix supply will vault upward, CEO says—in 2024, that is
Fierce Pharma
GSK
vaccines
drug shortages
Shingrix
shingles
Flag link:
The Ebola Vaccine Is Now Officially Here With Approval In Europe
The Ebola Vaccine Is Now Officially Here With Approval In Europe
Forbes
Europe
ebola virus
vaccines
Merck
Ervebo
Flag link:
Early data on Takeda's dengue vaccine is promising, but wait for the full dataset
Early data on Takeda's dengue vaccine is promising, but wait for the full dataset
Endpoints
Takeda
vaccines
dengue
clinical trials
Flag link:
Takeda's dengue shot 80% effective in massive phase 3 test
Takeda's dengue shot 80% effective in massive phase 3 test
Fierce Pharma
Takeda
dengue
vaccines
Sanofi
clinical trials
Flag link:
Sanofi’s Fluzone quadrivalent formulation gets FDA nod in older people
Sanofi’s Fluzone quadrivalent formulation gets FDA nod in older people
Pharmaceutical Business Review
Sanofi
Fluzone Quadrivalent
vaccines
FDA
influenza
Flag link:
J&J's Experimental Ebola Vaccine to be Deployed in the Congo to Help Stem Outbreak
J&J's Experimental Ebola Vaccine to be Deployed in the Congo to Help Stem Outbreak
BioSpace
JNJ
Congo
vaccines
WHO
ebola virus
Flag link:
Merck again borrows Gardasil supplies from CDC
Merck again borrows Gardasil supplies from CDC
Biopharma Dive
Merck
Gardasil
vaccines
CDC
HPV
Flag link:
GSK’s TB vaccine makes a big step forward towards licensing
GSK’s TB vaccine makes a big step forward towards licensing
Pharmaforum
GSK
vaccines
tuberculosis
M72/AS01E
Flag link:
How influenza discoveries could inspire a universal vaccine and new treatments
How influenza discoveries could inspire a universal vaccine and new treatments
Fierce Biotech
drug discovery
infuenza
antivirals
drug development
vaccines
Flag link:
CHMP backs world’s first Ebola vaccine from Merck, NewLink
CHMP backs world’s first Ebola vaccine from Merck, NewLink
Pharmaforum
Merck
ebola virus
vaccines
CHMP
EMA
Europe
NewLink Genetics
Flag link:
Two down, one to go: After decades-long campaign, type 3 polioviruses are set to be eradicated
Two down, one to go: After decades-long campaign, type 3 polioviruses are set to be eradicated
Stat
vaccines
polio
Flag link:
Bavarian Nordic to buy GSK’s rabies and tick-borne encephalitis vaccines
Bavarian Nordic to buy GSK’s rabies and tick-borne encephalitis vaccines
Pharmaceutical Business Review
Bavarian Nordic
GSK
vaccines
M&A
rabies
tick-borne encephalitis
Flag link:
FDA approves Roche’s Xofluza for patients at high risk of developing flu-related complications
FDA approves Roche’s Xofluza for patients at high risk of developing flu-related complications
Pharmaceutical Business Review
Roche
FDA
Xofluza
vaccines
influenza
Flag link:
Novavax Begins Phase III Study on Influenza Vaccine Candidate
Novavax Begins Phase III Study on Influenza Vaccine Candidate
Yahoo/Zacks.com
Novavax
vaccines
clinical trials
influenza
NanoFlu
Flag link:
Congo to start using J&J Ebola vaccine in November
Congo to start using J&J Ebola vaccine in November
Yahoo/Reuters
Congo
JNJ
ebola virus
vaccines
Flag link:

Pages